| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -6.4e-05 | 1 |